Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rogaratinib × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5 Tumor-Agnostic 3 Thoracic 2 Head & Neck 2 Breast 2 Sarcoma 1 Other neoplasm 1 Gastrointestinal 1

Conditions

Breast Cancer Metastatic 1

Interventions

Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 9 Biopsy 9 fludarabine phosphate 8 Busulfan 8 Whole-Body Irradiation 7 Surveys and Questionnaires 6 Mycophenolic Acid 6 Educational Status 6 Early Intervention, Educational 6 Carboplatin 6 fludarabine 5 Tacrolimus 5 Paclitaxel 5 Methotrexate 5 Methods 5 Melphalan 5 Epoetin Alfa 5 Decitabine 5 Cyclosporine 5 Colposcopy 5 Cisplatin 5 Celecoxib 5 Antilymphocyte Serum 5 Aminolevulinic Acid 5 Sulindac 4 Selenium 4 Radiotherapy 4 Patient Reported Outcome Measures 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡